Cofactor regeneration system

Patent metadata

Field	Value
Publication number	US-10975408-B2
Application number	US-201815899253-A
Country	US
Kind code	B2
Filing date	Feb 19, 2018
Priority date	Oct 3, 2011
Publication date	Apr 13, 2021
Grant date	Apr 13, 2021

Abstract

The present invention relates to cofactor regeneration systems, components and uses thereof and methods for generating and regenerating cofactors. The cofactor regeneration system comprises a first electron transfer component selected from a polypeptide comprising a NADH:acceptor oxido-reductase or NADPH:acceptor oxido-reductase, a second electron transfer component selected from a hydrogenase moiety and/or non-biological nanoparticles and an electronically conducting surface. The first and second electron transfer components are immobilised on the electrically conducting surface, and the first and second electron transfer components do not occur together in nature as an enzyme complex.

First claim

The invention claimed is:

1. A method for manufacturing a cofactor regeneration system, the method comprising:
a. identifying:
i. a first electron transfer component comprising a NADH: acceptor oxido-reductase that has activity in an assay which comprises:
a. adsorbing the NADH: acceptor oxido-reductase onto an electrode which is immersed in an electrochemical cell solution containing buffered electrolyte;
b. holding the electrode at a constant potential of −412 mV while an increasing concentration of NAD + is injected into said electrochemical cell solution; and
c. recording a change in the electrocatalytic current magnitude at the electrode; or
ii. a first electron transfer component comprising a NADPH: acceptor oxido-reductase that has activity in an assay which comprises:
a. adsorbing the NADPH: acceptor oxido-reductase onto an electrode which is immersed in an electrochemical cell solution containing buffered electrolyte;
b. holding the electrode at a constant potential of −412 mV while an increasing concentration of NADP+ is injected into said electrochemical cell solution; and
c. recording a change in the electrocatalytic current magnitude at the electrode; and
iii. a second electron transfer component comprising a hydrogenase moiety that has an electrocatalytic H + reduction current, electrocatalytic H 2 oxidation current, or a combination thereof, within 100 mV below or above the thermodynamic potential of the 2H + /H 2 couple under the experimental conditions, when tested in an assay comprising:
a. attaching the hydrogenase to an electrode such that the hydrogenase can exchange electrons directly with the electrode;
b. immersing the electrode in an electrochemical cell solution containing buffered electrolyte saturated with H 2 ; and
c. cycling the electrode potential between lower and upper limiting potentials; or
iv. a second electron transfer component comprising a non-biological nanoparticle that has an electrocatalytic H + reduction current, electrocatalytic H 2 oxidation current, or a combination thereof, within 100 mV below or above the thermodynamic potential of the 2H + /H 2 couple under the experimental conditions, when tested in an assay comprising:
a. attaching the non-biological nanoparticle to an electrode such that the non-biological nanoparticle can exchange electrons directly with the electrode;
b. immersing the electrode in an electrochemical cell solution containing buffered electrolyte saturated with H 2 ; and
c. cycling the electrode potential between lower and upper limiting potentials; and

b. providing the first electron transfer component, the second electron transfer component, and an electronically conducting surface;
wherein the first and second electron transfer components do not occur together in nature as an enzyme complex; and
c. immobilising the first and second electron transfer components on the electronically conducting surface so that in use electrons flow:
from the first electron transfer component via the electronically conducting surface to the second electron transfer component; or from the second electron transfer component via the electronically conducting surface to the first electron transfer component.

2. The method according to claim 1 , wherein the first electron transfer component is a diaphorase.

3. The method according to claim 1 , wherein the first electron transfer component comprises an amino acid sequence having at least 90% sequence identity to one or more sequences selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, and SEQ ID NO: 65; or wherein the second electron transfer component comprises an amino acid sequence having at least 90% sequence identity to one or more sequences selected from the group consisting of SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 52, and SEQ ID NO: 53.

4. A cofactor regeneration system comprising:
a. a first electron transfer component comprising:
i) a NADH: acceptor oxido-reductase that has activity in an assay which comprises:
a. adsorbing the NADH: acceptor oxido-reductase onto an electrode which is immersed in an electrochemical cell solution containing buffered electrolyte;
b. holding the electrode at a constant potential of −412 mV while an increasing concentration of NAD + is injected into said electrochemical cell solution; and
c. recording a change in the electrocatalytic current magnitude at the electrode; or

ii) a NADPH acceptor: oxido-reductase that has activity in an assay which comprises:
a. adsorbing the NADPH: acceptor oxido-reductase onto an electrode which is immersed in an electrochemical cell solution containing buffered electrolyte;
b. holding the electrode at a constant potential of −412 mV while an increasing concentration of NADP + is injected into said electrochemical cell solution; and
c. recording a change in the electrocatalytic current magnitude at the electrode; and

b. a second electron transfer component comprising:
i) a hydrogenase moiety that has an electrocatalytic H + reduction current, electrocatalytic H 2 oxidation current, or a combination thereof, within 100 mV below or above the thermodynamic potential of the 2H + /H 2 couple under the experimental conditions, when tested in an assay comprising:
a. attaching the hydrogenase to an electrode such that the hydrogenase can exchange electrons directly with the electrode;
b. immersing the electrode in an electrochemical cell solution containing buffered electrolyte saturated with H 2 ; and
c. cycling the electrode potential between lower and upper limiting potentials; or

ii) a non-biological nanoparticle that has an electrocatalytic H + reduction current, electrocatalytic H 2 oxidation current, or a combination thereof, within 100 mV below or above the thermodynamic potential of the 2H + /H 2 couple under the experimental conditions, when tested in an assay comprising:
a. attaching the non-biological nanoparticle to an electrode such that the non-biological nanoparticle can exchange electrons directly with the electrode;
b. immersing the electrode in an electrochemical cell solution containing buffered electrolyte saturated with H 2 ; and
c. cycling the electrode potential between lower and upper limiting potentials; and

c. an electronically conducting surface; and
wherein the first and second electron transfer components are immobilised on the electronically conducting surface; and
wherein the first and second electron transfer components do not occur together in nature as an enzyme complex; and
wherein the cofactor regeneration system is configured so that in use electrons flow:
from the first electron transfer component via the electronically conducting surface to the second electron transfer component; or
from the second electron transfer component via the electronically conducting surface to the first electron transfer component.

5. The method according to claim 1 , wherein t

Assignees

• Univ Oxford Innovation Ltd
• Humboldt Univ Zu Berlin

Inventors

• Vincent Kylie
• Lauterbach Lars
• Lenz Oliver

Classifications

• C12N9/0051

  acting on a sulfur group of donors (1.8) · CPC title

• C12N9/0036

  acting on NADH or NADPH (1.6) · CPC title

• C12Y108/01004

  Dihydrolipoyl dehydrogenase (1.8.1.4), i.e. lipoamide-dehydrogenase · CPC title

• C12P19/36 Primary

  Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate · CPC title

• C12Y106/99001

  NADPH dehydrogenase (1.6.99.1) · CPC title